Copyright
©The Author(s) 2016.
World J Gastroenterol. Aug 28, 2016; 22(32): 7289-7300
Published online Aug 28, 2016. doi: 10.3748/wjg.v22.i32.7289
Published online Aug 28, 2016. doi: 10.3748/wjg.v22.i32.7289
Group | No. of patients | Treatments | Child-Pugh A | Survival |
Luo et al[81] | 164 (84 vs 80) | TACE vs Control | Not known | 1-yr survival 30.9% vs 9.2% |
Niu et al[82] | 150 (115 vs 35) | TACE vs Control | 88 vs 21 | Median survival 8.67 mo vs 14 mo |
Kim et al[83] | 110 (49 vs 61) | TACE vs TACI | 30 vs 22 | Median survival 14.9 mo vs 4.4 mo |
Peng et al[25] | 603 (402 vs 201) | TACE vs Resection | 389 vs 197 | Median survival 42 mo vs 14.1 mo |
- Citation: Chan SL, Chong CC, Chan AW, Poon DM, Chok KS. Management of hepatocellular carcinoma with portal vein tumor thrombosis: Review and update at 2016. World J Gastroenterol 2016; 22(32): 7289-7300
- URL: https://www.wjgnet.com/1007-9327/full/v22/i32/7289.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i32.7289